↓ Skip to main content

Dove Medical Press

Article Metrics

Establishment and characterization of a receptor-negative, hormone-nonresponsive breast cancer cell line from an Iraqi patient

Overview of attention for article published in Breast cancer targets and therapy, August 2015
Altmetric Badge

About this Attention Score

  • Among the highest-scoring outputs from this source (#41 of 176)
  • Good Attention Score compared to outputs of the same age (74th percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter
1 tweeter
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
8 Mendeley
Title
Establishment and characterization of a receptor-negative, hormone-nonresponsive breast cancer cell line from an Iraqi patient
Published in
Breast cancer targets and therapy, August 2015
DOI 10.2147/bctt.s74509
Pubmed ID
Authors

Ahmed Al-Shammari, Mortadha Alshami, Mahfoodha Umran, Asmaa Almukhtar, Nahi Yaseen, Ayman Hussien, Khansaa Raad

Abstract

A new breast cancer cell line (AMJ13) has been established from an Iraqi breast cancer patient. It is considered unique because it is the first for an Iraqi population, and is expected to be a useful tool in breast cancer research. The AMJ13 cell line was established from the primary tumor of a 70-year-old Iraqi woman with a histological diagnosis of infiltrating ductal carcinoma. The cells were morphologically characterized by light and scanning electron microscopy, and found to be elongated multipolar epithelial-like cells with a population doubling time of 22 hours. The anchorage-independent growth ability test showed that the cells were able to grow in semisolid agarose, confirming their transformed nature. Cytogenetic study of these cells showed chromosomal aberrations with many structural and numerical abnormalities, producing chromosomes of unknown origin called marker chromosomes. Immunocytochemistry showed that the estrogen receptor and the progesterone receptor were not expressed, and a weak positive result was found for HER2/neu gene expression. AMJ13 cells were positive for BRCA1 and BRCA2, as well as for vimentin. This cell line should be useful when testing new therapies for breast cancer in the Middle East.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Iraq 1 13%
Unknown 7 88%

Demographic breakdown

Readers by professional status Count As %
Unspecified 2 25%
Lecturer 2 25%
Student > Master 1 13%
Student > Ph. D. Student 1 13%
Professor > Associate Professor 1 13%
Other 1 13%
Readers by discipline Count As %
Unspecified 3 38%
Biochemistry, Genetics and Molecular Biology 2 25%
Agricultural and Biological Sciences 1 13%
Immunology and Microbiology 1 13%
Medicine and Dentistry 1 13%
Other 0 0%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 May 2019.
All research outputs
#3,528,009
of 13,727,890 outputs
Outputs from Breast cancer targets and therapy
#41
of 176 outputs
Outputs of similar age
#60,228
of 238,623 outputs
Outputs of similar age from Breast cancer targets and therapy
#3
of 9 outputs
Altmetric has tracked 13,727,890 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 176 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 238,623 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 6 of them.